secwatch.observer — SEC 8-K summary
======================================

Issuer:     GLOBUS MEDICAL INC (GMED)
CIK:        0001237831
Form:       8-K
Filed at:   2026-02-24T23:59:59+00:00
Accession:  0001628280-26-011124
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Globus Medical Q4 revenue $826.4M (+25.7% YoY); EPS $1.03 GAAP / $1.28 non-GAAP
-------------------------------------------------------------------------------

- Q4 worldwide net sales $826.4M, up 25.7% YoY; base business ex-Nevro up 10.6%.
- GAAP diluted EPS $1.03 (vs $0.19); non-GAAP diluted EPS $1.28 (vs $0.84), up 52.1%.
- Full year 2025 revenue $2,938.9M (+16.7%); GAAP EPS $3.92; non-GAAP EPS $3.98.
- 2026 guidance: revenue $3.18-3.22B; non-GAAP EPS raised to $4.40-4.50 from $4.30-4.40.
- US Spine revenue grew 10% in Q4; Enabling Technologies grew 19% over prior-year quarter.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1237831/000162828026011124/0001628280-26-011124-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1237831/000162828026011124/gmed-20260224.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-011124

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer